Competition for skilled workers. The growing importance of specialists in the pharmaceutical and medical equipment industry
According to the 13th edition of the Antal Salary Report, the average monthly salary for specialists and managers in the pharmaceutical and medical equipment industry was PLN 15,652 gross, compared to PLN 14,637 gross in the 12th edition of the study. This represents a 7% increase compared to the previous year.

The pharmaceutical and medical equipment industry in Poland is experiencing dynamic salary growth. Market development, an expanding portfolio, consumer demand, and intense competition are driving the sector, which results in pay raises for employees.
Dynamic salary growth
Since 2022, there has been a steady increase in salaries in the pharmaceutical and medical equipment industry. Average salaries have risen by 5-7% over the past year, influenced by the increase in the minimum wage. The average salary level is dependent on the position, candidate’s portfolio, and the size of the company.
Poland is a leader in the dietary supplements and OTC drugs market, reflecting a growing focus on health, preventive care, and awareness of medical screenings. The increasing interest in a healthy lifestyle is driving higher sales and wages in this industry, adds Marta Lebuda, Sector Manager Antal Sales & Marketing, Antal Pharma & Medical Devices.
Competition for qualified specialists

In the pharmaceutical industry, all roles are interconnected vessels, each being crucial and key from a business perspective. From clinical trials to drug registration, safety monitoring, medical support, and, of course, sales and marketing, companies are now focusing on individuals with experience in the specific area they are recruiting for. If it’s the OTC/Supplements market, they will seek candidates with experience and contacts with key networks in the area. If it’s the development of new drugs in the cardiology field, the natural choice for the company will be to acquire a candidate from the competition who can quickly promote the drug among Key Opinion Leaders in that therapeutic area and take care of the most crucial centers, comments Marta Lebuda, Sector Manager Antal Sales & Marketing Pharma & Medical Devices.
An unconventional yet crucial tool in the pharmaceutical industry – marketing
When we observe the loss of patents in original companies, we can expect that the structures of generic companies will expand as they introduce equivalents of those drugs. The increase in demand is observed as business operations expand into new business lines, new therapeutic areas, and new drugs entering the promotion stage. As a result, demand is directly dependent on the company’s development and product portfolio, summarizes Marta Lebuda, Sector Manager Antal Sales & Marketing Pharma & Medical Devices.
Published: September 26, 2024 by Antal PR Team























